FDA Drug Application (202595) for OSELTAMIVIR PHOSPHATE by NATCO PHARMA LTD

Back to FDA Applications sponsored by NATCO PHARMA LTD

Application Number202595
Product Number001
FormCAPSULE;ORAL
DosageEQ 30MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOSELTAMIVIR PHOSPHATE
Active IngredientOSELTAMIVIR PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient OSELTAMIVIR PHOSPHATE2


Back to FDA Applications sponsored by NATCO PHARMA LTD